Literature DB >> 11264345

DNase protection analysis of retrovirus integrase at the viral DNA ends for full-site integration in vitro.

A Vora1, D P Grandgenett.   

Abstract

Retrovirus intasomes purified from virus-infected cells contain the linear viral DNA genome and integrase (IN). Intasomes are capable of integrating the DNA termini in a concerted fashion into exogenous target DNA (full site), mimicking integration in vivo. Molecular insights into the organization of avian myeloblastosis virus IN at the viral DNA ends were gained by reconstituting nucleoprotein complexes possessing intasome characteristics. Assembly of IN-4.5-kbp donor complexes capable of efficient full-site integration appears cooperative and is dependent on time, temperature, and protein concentration. DNase I footprint analysis of assembled IN-donor complexes capable of full-site integration shows that wild-type U3 and other donors containing gain-of-function attachment site sequences are specifically protected by IN at low concentrations (<20 nM) with a defined outer boundary mapping ~20 nucleotides from the ends. A donor containing mutations in the attachment site simultaneously eliminated full-site integration and DNase I protection by IN. Coupling of wild-type U5 ends with wild-type U3 ends for full-site integration shows binding by IN at low concentrations probably occurs only at the very terminal nucleotides (<10 bp) on U5. The results suggest that assembly requires a defined number of avian IN subunits at each viral DNA end. Among several possibilities, IN may bind asymmetrically to the U3 and U5 ends for full-site integration in vitro.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11264345      PMCID: PMC114847          DOI: 10.1128/JVI.75.8.3556-3567.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

1.  Substrate sequence selection by retroviral integrase.

Authors:  H Zhou; G J Rainey; S K Wong; J M Coffin
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

2.  Molecular biology. Transposase team puts a headlock on DNA.

Authors:  T L Williams; T A Baker
Journal:  Science       Date:  2000-07-07       Impact factor: 47.728

3.  A 32,000-dalton nucleic acid-binding protein from avian retravirus cores possesses DNA endonuclease activity.

Authors:  D P Grandgenett; A C Vora; R D Schiff
Journal:  Virology       Date:  1978-08       Impact factor: 3.616

4.  Relationship of avian retrovirus DNA synthesis to integration in vitro.

Authors:  Y M Lee; J M Coffin
Journal:  Mol Cell Biol       Date:  1991-03       Impact factor: 4.272

5.  The avian retroviral IN protein is both necessary and sufficient for integrative recombination in vitro.

Authors:  R A Katz; G Merkel; J Kulkosky; J Leis; A M Skalka
Journal:  Cell       Date:  1990-10-05       Impact factor: 41.582

6.  Correct integration of retroviral DNA in vitro.

Authors:  P O Brown; B Bowerman; H E Varmus; J M Bishop
Journal:  Cell       Date:  1987-05-08       Impact factor: 41.582

7.  Avian retrovirus DNA internal attachment site requirements for full-site integration in vitro.

Authors:  R Chiu; D P Grandgenett
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

8.  The IN protein of Moloney murine leukemia virus processes the viral DNA ends and accomplishes their integration in vitro.

Authors:  R Craigie; T Fujiwara; F Bushman
Journal:  Cell       Date:  1990-08-24       Impact factor: 41.582

9.  Structure-based mutagenesis of the human immunodeficiency virus type 1 DNA attachment site: effects on integration and cDNA synthesis.

Authors:  H E Brown; H Chen; A Engelman
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

10.  Retroviral DNA integration: structure of an integration intermediate.

Authors:  T Fujiwara; K Mizuuchi
Journal:  Cell       Date:  1988-08-12       Impact factor: 41.582

View more
  17 in total

1.  Multiple modifications allow high-titer production of retroviral vectors carrying heterologous regulatory elements.

Authors:  Juraj Hlavaty; Anika Stracke; Dieter Klein; Brian Salmons; Walter H Günzburg; Matthias Renner
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

2.  Retroviral DNA integration: reaction pathway and critical intermediates.

Authors:  Min Li; Michiyo Mizuuchi; Terrence R Burke; Robert Craigie
Journal:  EMBO J       Date:  2006-02-16       Impact factor: 11.598

Review 3.  Nucleocapsid protein function in early infection processes.

Authors:  James A Thomas; Robert J Gorelick
Journal:  Virus Res       Date:  2008-02-14       Impact factor: 3.303

4.  Biochemical and biophysical analyses of concerted (U5/U3) integration.

Authors:  Duane P Grandgenett; Sibes Bera; Krishan K Pandey; Ajaykumar C Vora; Jacob Zahm; Sapna Sinha
Journal:  Methods       Date:  2008-11-29       Impact factor: 3.608

5.  Catalytically-active complex of HIV-1 integrase with a viral DNA substrate binds anti-integrase drugs.

Authors:  Akram Alian; Sarah L Griner; Vicki Chiang; Manuel Tsiang; Gregg Jones; Gabriel Birkus; Romas Geleziunas; Andrew D Leavitt; Robert M Stroud
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-04       Impact factor: 11.205

6.  Integration of rous sarcoma virus DNA: a CA dinucleotide is not required for integration of the U3 end of viral DNA.

Authors:  Jangsuk Oh; Kevin W Chang; Stephen H Hughes
Journal:  J Virol       Date:  2008-09-03       Impact factor: 5.103

7.  Differential assembly of Rous sarcoma virus tetrameric and octameric intasomes is regulated by the C-terminal domain and tail region of integrase.

Authors:  Sibes Bera; Krishan K Pandey; Hideki Aihara; Duane P Grandgenett
Journal:  J Biol Chem       Date:  2018-09-05       Impact factor: 5.157

8.  A C-terminal "Tail" Region in the Rous Sarcoma Virus Integrase Provides High Plasticity of Functional Integrase Oligomerization during Intasome Assembly.

Authors:  Krishan K Pandey; Sibes Bera; Ke Shi; Hideki Aihara; Duane P Grandgenett
Journal:  J Biol Chem       Date:  2017-02-08       Impact factor: 5.157

9.  Efficient concerted integration by recombinant human immunodeficiency virus type 1 integrase without cellular or viral cofactors.

Authors:  Sapna Sinha; Michael H Pursley; Duane P Grandgenett
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

10.  Inhibition of human immunodeficiency virus type 1 concerted integration by strand transfer inhibitors which recognize a transient structural intermediate.

Authors:  Krishan K Pandey; Sibes Bera; Jacob Zahm; Ajaykumar Vora; Kara Stillmock; Daria Hazuda; Duane P Grandgenett
Journal:  J Virol       Date:  2007-09-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.